Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary pick disease

Journal of Medical Genetics

Volumn 34, Issue 1, 1997, Pages 63-72

  Tibben, A ^a   Stevens, M ^a   De Wert, G M W R ^a,b   Niermeijer, M F ^a   Van Duijn, C M ^a   Van Swieten, J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Institute of Bioethics   (Netherlands)

Author keywords

Alzheimer's disease; Pick disease; Presymptomatic resting

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DNA;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; DEMOGRAPHY; DNA DETERMINATION; FAMILY PLANNING; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MOOD; PATIENT COUNSELING; PICK PRESENILE DEMENTIA; PRENATAL SCREENING; PRIORITY JOURNAL; SYMPTOM; TREATMENT PLANNING; VASCULAR AMYLOIDOSIS;

EID: 0031037982     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.34.1.63     Document Type: Article

References (17)

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72:971-83.
2. Gispert S, Twells R, Orozco G, et al. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 1993;4:295-9.
3. Haan J, Hardy JA, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: its importance for Alzheimer research. Trends Neurosci 1991;14:231-4.
4. Mullan M, Crawford F, Buchanan J. Technical feasibility of genetic testing for Alzheimer's disease. Alzheimer Dis Assoc Disord 1994;8:102-15.
5. Buxton J, Shelbourne P, Davies J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547-8.
6. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
7. Hoogeveen AT, Willemsen R, Meyer N, et al. Characterization and localization of the Huntington disease gene product. Hum Mol Genet 1993;2:2069-73.
8. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218-21.
9. Heston LL, Mastri AR. Age at onset of Pick's and Alzheimer's dementia: implications for diagnosis and research. J Gerontol 1982;37:422-4.
10. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-23.
11. Neary D, Snowden JS, Northen B, Goulding P. Dementia of frontal lobe type. J Neural Neurosurg Psychiatry 1988;51:353-61.
12. Mendez MF, Selwood A, Mastri AR, Frey W. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993;43:289-92.
13. Harper PS. Huntington disease and the abuse of genetics. Am J Hum Genet 1992;50:460-4.
14. Markel DS, Young AB, Penney JB. At risk person's attitude toward presymptomatic testing in Huntington disease. Am J Med Genet 1987;26:295-305.
15. Meissen GJ, Berchek RL. Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet 1987;26:283-93.
16. Kessler S, Field T, Worth L, Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 1987;26:259-70.
17. Terrenoire G. Huntington's disease and the ethics of genetic prediction. J Med Ethics 1992;18:79-85.